Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Ibrutinib's trials
CAN3001
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Ibrutinib
Ongoing
Recruiting
Phase 3
Open NCT01804686 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
